胆管癌的分子生物学及其对患者管理中的向治疗的影响
T M Gilbert1, L Randle2, M Quinn3
1Hepatobiliary Surgery, Liverpool University Hospitals NHS FT, Liverpool, UK; Department of Pharmacology and Therapeutics, Institute of Systems Integrative and Molecular Biology, University of Liverpool, Liverpool, UK.
概括
胆管癌 (CCA) 的治疗具有挑战性. 本综述涵盖了针对CCA的向疗法,包括已批准的药物和基于分子病原学的未来治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 胆管癌 (CCA) 是一种难以治疗的癌症,通常在晚期被诊断出来.
- 高通量基因测序推进了对癌症分子基础的理解.
- 向疗法为特定的遗传突变提供了新的治疗策略.
研究的目的:
- 审查胆瘤癌 (CCA) 的分子病原性.
- 突出目前针对CCA的向治疗方法.
- 讨论潜在的未来针对性治疗CCA.
主要方法:
- 审查当前的科学文献.
- 对CCA分子病原学的分析.
- 识别可操作的突变和有针对性的疗法.
主要成果:
- 目前有三种针对性疗法被批准用于CCA:Ivosidenib (IDH1突变) 和Infigratinib/Pemigatinib (FGFR2融合).
- 高达40%的CCA患者可能具有可操作的突变.
- 目前正在进行的研究正在确定新的治疗点.
结论:
- 向疗法是CCA治疗的一个有希望的方法.
- 进一步了解CCA的分子生物学可能会产生更多的治疗选择.
- 个性化医疗策略对于改善CCA患者的治疗结果至关重要.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.2K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K